Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-12-28, Stock:LLY, The news for the past five days is as follows:
2018-12-20: NEWS1: Lilly's Shares Rise on Robust 2019 View, Dividend Hike.NEWS2: Allergan Drops, Stops Textured Breast Implant Sales in Europe.NEWS3: Allergan Drops, Stops Textured Breast Implant Sales in Europe.NEWS4: Supernus Pharma's ADHD drug meets main goal in study on adolescents.NEWS5: Allergan Drops, Stops Textured Breast Implant Sales in Europe.NEWS6: Company News For Dec 20, 2018.NEWS7: Company News For Dec 20, 2018.NEWS8: The Zacks Analyst Blog Highlights: Eli Lilly, Mitsubishi UFJ, Thermo Fisher, Oracle and Ecolab.NEWS9: Eli Lilly and Pfizer Are Boosting Dividends.NEWS10: Company News For Dec 20, 2018.NEWS11: Eli Lilly CEO on drug prices: Patients are paying too much out-of-pocket costs.NEWS12: Eli Lilly's Technical Setup Looks So-So, So Be Ready to Take Action.NEWS13: Eli Lilly Technical Setup Looks So-So, So Be Ready to Take Action.NEWS14: Top Analyst Reports for Eli Lilly, Mitsubishi UFJ & Thermo Fisher.NEWS15: Top Analyst Reports for Eli Lilly, Mitsubishi UFJ & Thermo Fisher.NEWS16: Fighting the Fed: Cramer's 'Mad Money' Recap (Wednesday 12/19/18).NEWS17: Eli Lilly CEO talks winning on migraine treatments.NEWS18: 'It's a horse race between three great companies': Eli Li....NEWS19: Cramer Remix: If you can handle the allegations, these companies could be profitable long-term plays.NEWS20: Cramer Remix: If you can handle the allegations, these companies could be profitable long-term plays.
2018-12-21: NEWS1: Pfizer Xtandi Succeeds in Late-Stage Prostate Cancer Study.NEWS2: Pfizer Xtandi Succeeds in Late-Stage Prostate Cancer Study.NEWS3: Interesting LLY Put And Call Options For March 2019.NEWS4: Interesting LLY Put And Call Options For March 2019.NEWS5: Pfizer Xtandi Succeeds in Late-Stage Prostate Cancer Study.NEWS6: Pharma Stock Roundup: GSK, PFE Ink Consumer Health JV, JNJ Hit by Talc Allegations.NEWS7: Lilly's Shares Rise on Robust 2019 View, Dividend Hike.NEWS8: Lilly's Shares Rise on Robust 2019 View, Dividend Hike.
2018-12-24: NEWS1: This Drug Is Expected to Be a Significant Driver for Pfizer.
2018-12-26: NEWS1: Will Big Pharma's Giant Maw Scoop Up These Small-Cap Players?.NEWS2: Noteworthy ETF Outflows: MTUM, BA, DIS, LLY.NEWS3: Noteworthy ETF Outflows: MTUM, BA, DIS, LLY.NEWS4: Bayer (BAYRY) Faces Generic Threat & Rising Competition.NEWS5: Bayer (BAYRY) Faces Generic Threat & Rising Competition.NEWS6: Bayer (BAYRY) Faces Generic Threat & Rising Competition.
2018-12-27: NEWS1: Teva Stock Rises on Patent Settlement With Neos Therapeutics.NEWS2: Teva Stock Rises on Patent Settlement With Neos Therapeutics.NEWS3: Teva Stock Rises on Patent Settlement With Neos Therapeutics.NEWS4: Forget J&J, Buy These 3 Big Drug Stocks Instead in 2019.NEWS5: Forget J&J, Buy These 3 Big Drug Stocks Instead in 2019.NEWS6: Forget J&J, Buy These 3 Big Drug Stocks Instead in 2019.NEWS7: Innovent, Lilly Co-developed Tyvyt Gets China's NMPA Approval For CHL.NEWS8: Innovent, Lilly Co-developed Tyvyt Gets China's NMPA Approval For CHL.

Answer: Rise